BNTX
BioNTech SE
93.92
2 x 66.71
1 x 100.00
bid
ask
+
0.87
0.93%
2 @ 08:55 AM
94.71 +0.79 (0.84%)
| Ytd | -1.34% | |
| 1y | -12.64% |
92.56
day range
94.00
79.52
52 week range
124.00
| Open | 93.07 | Prev Close | 93.05 | Low | 92.56 | High | 94.00 | Mkt Cap | 23.75B |
| Vol | 530.08K | Avg Vol | 953.50K | EPS | -5.78 | P/E | N/A | Forward P/E | -18.58 |
| Beta | 1.32 | Short Ratio | 2.50 | Inst. Own | 20.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 06-02 | Earning | 08-04 | 50-d Avg | 93.65 | 200-d Avg | 99.11 | 1yr Est | 121.52 |
| Income Statement | |||
| Total Revenue | 118.10M | ||
| Revenues (USD) | 135.75M | ||
| Cost of Revenue | 71.40M | ||
| Gross Profit | 46.70M | ||
| Operating Expenses | 724.20M | ||
| Research and Development Expense | 557.00M | ||
| Selling, General and Administrative Expense | 150.80M | ||
| Operating Income | -677.50M | ||
| Interest Expense | 11.20M | ||
| Income Tax Expense | -36.20M | ||
| Net Income | -531.90M | ||
| Net Income Common Stock | -531.90M | ||
| Net Income Common Stock (USD) | -611.38M | ||
| Consolidated Income | -531.90M | ||
| Earnings per Basic Share | -2.10 | ||
| Earnings per Basic Share (USD) | -2.41 | ||
| Earnings per Diluted Share | -2.10 | ||
| Earning Before Interest & Taxes (EBIT) | -556.90M | ||
| Earning Before Interest & Taxes (USD) | -640.11M | ||
| Weighted Average Shares | 239.97M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.94B | ||
| Cash and Equivalents (USD) | 11.42B | ||
| Investments | 7.17B | ||
| Investments Current | 4.88B | ||
| Investments Non-Current | 2.29B | ||
| Trade and Non-Trade Receivables | 539.20M | ||
| Current Assets | 15.53B | ||
| Property, Plant & Equipment Net | 1.32B | ||
| Total Assets | 21.07B | ||
| Debt Current | 134.20M | ||
| Total Debt | 472.30M | ||
| Current Liabilities | 1.77B | ||
| Debt Non-Current | 338.10M | ||
| Total Liabilities | 2.38B | ||
| Accumulated Retained Earnings (Deficit) | 17.43B | ||
| Shareholders Equity | 18.70B | ||
| Shareholders Equity (USD) | 21.49B | ||
| Assets Non-Current | 5.54B | ||
| Total Debt (USD) | 542.87M | ||
| Deferred Revenue | 846.20M | ||
| Goodwill and Intangible Assets | 1.92B | ||
| Inventory | 103.80M | ||
| Liabilities Non-Current | 611.30M | ||
| Trade and Non-Trade Payables | 468.80M | ||
| Tax Assets | 78.80M | ||
| Tax Liabilities | 91.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 121.30M | ||
| Net Cash Flow from Financing | 26.40M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.26B | ||
| Capital Expenditure | -55.20M | ||
| Issuance (Repayment) of Debt Securities | 26.40M | ||
| Net Cash Flow from Investing | 2.65B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.73B | ||
| Net Cash Flow from Operations | -421.00M | ||
| Effect of Exchange Rate Changes on Cash | -3.40M | ||
| Share Based Compensation | 20.70M | ||